Get the Stockscreener App
13.55
1.50%
0.20
After Hours:
13.55
Si Bone Inc stock is traded at $13.55, with a volume of 654.60K.
It is up +1.50% in the last 24 hours and up +3.28% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$13.35
Open:
$13.34
24h Volume:
654.60K
Relative Volume:
1.09
Market Cap:
$599.50M
Revenue:
$200.93M
Net Income/Loss:
$-18.91M
P/E Ratio:
-30.66
EPS:
-0.4419
Net Cash Flow:
$-9.09M
1W Performance:
+9.63%
1M Performance:
+3.28%
6M Performance:
-11.78%
1Y Performance:
-4.91%
1-Day Range:
$13.07
$13.67
1-Week Range:
$11.80
$13.67
52-Week Range:
$11.80
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
13.55 | 590.65M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SI-BONE (SIBN) director Dunn sells small stake to cover RSU taxes - Stock Titan
Price-Driven Insight from (SIBN) for Rule-Based Strategy - Stock Traders Daily
Hussman Strategic Advisors Inc. Purchases Shares of 84,000 SiBone $SIBN - MarketBeat
SiBone (NASDAQ:SIBN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026 - The Manila Times
SI-BONE investors can hear management at BofA conference May 12 - Stock Titan
SiBone (NASDAQ:SIBN) Short Interest Update - MarketBeat
Should I hold SI-BONE (SIBN) stock today | Q4 2025: EPS Exceeds ExpectationsWall Street Picks - Newser
SiBone (NASDAQ:SIBN) Hits New 52-Week LowTime to Sell? - MarketBeat
Needham maintains SI-BONE (SIBN) buy recommendation - MSN
Impax Asset Management Group plc Has $23.66 Million Stock Holdings in SiBone $SIBN - MarketBeat
BlackRock (SIBN) files Schedule 13G/A reporting 6.9% ownership of SI-BONE - Stock Titan
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy - MSN
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
(SIBN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
SIBN (SI-BONE Inc.) Q4 2025 EPS far exceeds analyst estimates, shares gain roughly three percent today.Rating Upgrade - Xã Thanh Hà
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SI-BONE (NASDAQ: SIBN) sets 2026 virtual meeting, director and pay votes - Stock Titan
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 - GlobeNewswire
Is SI-BONE (SIBN) stock worth trading today (Sideways) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
SI-BONE schedules May 11 earnings release, 4:30 p.m. ET call - Stock Titan
SiBone (NASDAQ:SIBN) Downgraded by Wall Street Zen to Hold - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Q2 2025 Earnings Call Transcript - MSN
SiBone (NASDAQ:SIBN) Stock Price Down 4.8% on Analyst Downgrade - MarketBeat
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Truist Financial Lowers SiBone (NASDAQ:SIBN) Price Target to $20.00 - MarketBeat
Truist Cuts Price Target on SI-BONE to $20 From $24, Keeps Buy Rating - marketscreener.com
(SIBN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
SiBone (NASDAQ:SIBN) Shares Down 6.8%Here's Why - MarketBeat
SI-BONE’s Long-Term Vision Takes Hold: Record Revenue Growth, Positive Adjusted EBITDA, and Expanding Innovation and Distribution - Orthopedics This Week
Bull Run: Is SI BONE Inc a turnaround story2026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Chart Watch: What is the earnings history of SI BONE Inc2026 EndofYear Setup & Free Community Consensus Stock Picks - baoquankhu1.vn
Director Greg Hinckley adds 3,085 SI-BONE (SIBN) shares via options - Stock Titan
Street Watch: Is SI BONE Inc stock showing strong momentum2026 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Is SI-BONE (SIBN) Stock in a Downtrend | Price at $13.39, Down 3.88%Index Investing - Newser
Investment Report: Can SI BONE Inc weather a recessionExit Point & Scalable Portfolio Growth Methods - baoquankhu1.vn
SiBone $SIBN Stake Lowered by JPMorgan Chase & Co. - MarketBeat
SiBone (NASDAQ:SIBN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Si-Bone CFO Maheshwari sells $42,707 in stock By Investing.com - Investing.com South Africa
SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 1,799 Shares - MarketBeat
SiBone (NASDAQ:SIBN) CFO Sells $42,702.66 in Stock - MarketBeat
SiBone (NASDAQ:SIBN) SVP Sells $17,168.10 in Stock - MarketBeat
Si-Bone CFO Maheshwari sells $42,707 in stock - Investing.com
Tax-driven share sale by SI-BONE (SIBN) chief legal officer - Stock Titan
SI-BONE Inc stock: Why this medtech innovator could reshape spine surgery - AD HOC NEWS
SIBN Stock Analysis: SI-BONE Inc. Medtech Stock Posts Mild Daily Gain At 13.12 - Newser
Will SI BONE Inc benefit from rising consumer demand2026 Historical Comparison & Fast Entry and Exit Trade Plans - baoquankhu1.vn
SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape - AD HOC NEWS
SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest - MarketBeat
SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones - MSN
SiBone (NASDAQ:SIBN) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):